DarioHealth price target raised to $5.50 from $2.50 at Alliance Global Partners

Alliance Global Partners raised the firm’s price target on DarioHealth to $5.50 from $2.50 and keeps a Buy rating on the shares after the company announced the acquisition of Twill, a digital health firm with strong offerings in well-being and behavioral health. The firm sees Twill as Dario’s best acquisition with nearly zero functionality or customer overlap, an “impressive roster of customers,” and a similar “consumer-centric” mindset, says the analyst, who notes that Dario also raised $22.4M in gross proceeds via a private placement of convertible preferred stock alongside the acquisition.